DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS

Introduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method. The use of 3-month injectable contraceptives also has drawbacks or side effe...

Full description

Saved in:
Bibliographic Details
Main Authors: Amellia Mardhika, Yolanda Dwi Safitri, Lailatul Fadliyah, Riris Medawati
Format: Article
Language:English
Published: Universitas Airlangga 2021-10-01
Series:Journal of Vocational Nursing
Subjects:
Online Access:https://e-journal.unair.ac.id/JoViN/article/view/30327
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560048628662272
author Amellia Mardhika
Yolanda Dwi Safitri
Lailatul Fadliyah
Riris Medawati
author_facet Amellia Mardhika
Yolanda Dwi Safitri
Lailatul Fadliyah
Riris Medawati
author_sort Amellia Mardhika
collection DOAJ
description Introduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method. The use of 3-month injectable contraceptives also has drawbacks or side effects, one of which is menstrual cycle disorders. The purpose of this study was to determine the description of menstrual cycle disorders in users of 3-month injectable contraceptives. Methods: This study used a descriptive design. The population in this study was women of childbearing age who used injection contraception for 3-months at the sub-health center of Tanjung Village. The total population in this study was 48 samples. The sampling technique was carried out by the total sampling technique. The statistical analysis used in this study was descriptive analysis (number and prosentase). Results: The results of the study showed that using 3-month injectable contraceptives were found that 29 respondents (60.4%) experienced amenorrhea, 15 respondents (31.3%) spotting, and 4 respondents (8.3%) did not experience menstrual cycle disorders. Conclusion: Most users of 3-month injectable contraceptives experience amenorrhea.
format Article
id doaj-art-9040613ceaae4895997113ce6dd6d344
institution Kabale University
issn 2775-0280
2722-7251
language English
publishDate 2021-10-01
publisher Universitas Airlangga
record_format Article
series Journal of Vocational Nursing
spelling doaj-art-9040613ceaae4895997113ce6dd6d3442025-01-05T05:30:08ZengUniversitas AirlanggaJournal of Vocational Nursing2775-02802722-72512021-10-01229710010.20473/jovin.v2i2.3032724810DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERSAmellia Mardhika0Yolanda Dwi Safitri1Lailatul Fadliyah2Riris Medawati3(Sinta ID: 6719524 ; H-index: 0); Faculty of Vocational Studies, Universitas AirlanggaFaculty of Vocational Studies, Universitas AirlanggaFaculty of Vocational Studies, Universitas AirlanggaFaculty of Vocational Studies, Universitas AirlanggaIntroduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method. The use of 3-month injectable contraceptives also has drawbacks or side effects, one of which is menstrual cycle disorders. The purpose of this study was to determine the description of menstrual cycle disorders in users of 3-month injectable contraceptives. Methods: This study used a descriptive design. The population in this study was women of childbearing age who used injection contraception for 3-months at the sub-health center of Tanjung Village. The total population in this study was 48 samples. The sampling technique was carried out by the total sampling technique. The statistical analysis used in this study was descriptive analysis (number and prosentase). Results: The results of the study showed that using 3-month injectable contraceptives were found that 29 respondents (60.4%) experienced amenorrhea, 15 respondents (31.3%) spotting, and 4 respondents (8.3%) did not experience menstrual cycle disorders. Conclusion: Most users of 3-month injectable contraceptives experience amenorrhea.https://e-journal.unair.ac.id/JoViN/article/view/30327injectable contraceptivesmenstruationamenorrheaspotting
spellingShingle Amellia Mardhika
Yolanda Dwi Safitri
Lailatul Fadliyah
Riris Medawati
DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
Journal of Vocational Nursing
injectable contraceptives
menstruation
amenorrhea
spotting
title DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
title_full DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
title_fullStr DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
title_full_unstemmed DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
title_short DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS
title_sort description of menstrual cycle disorders in 3 months injectable contraceptive users
topic injectable contraceptives
menstruation
amenorrhea
spotting
url https://e-journal.unair.ac.id/JoViN/article/view/30327
work_keys_str_mv AT amelliamardhika descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers
AT yolandadwisafitri descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers
AT lailatulfadliyah descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers
AT rirismedawati descriptionofmenstrualcycledisordersin3monthsinjectablecontraceptiveusers